In a potential game changer for patients with type 2 diabetes, a team of researchers at the Diabetes, Obesity, and Metabolism Institute (DOMI) at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target ...
Aug 4, 2022
0
107
It's been used for thousands of years to treat a variety of illnesses—and now acupuncture could also help fight one of the 21st century's biggest health challenges.
Aug 2, 2022
0
3
Both children with type 1 diabetes and their closest family members are at increased risk of mental health problems compared with those without the disease, according to a large study by researchers at Karolinska Institutet ...
Aug 1, 2022
0
49
A vial of insulin cost $25 in 1995, back when Chris Noble was 5 years old and just learning how to manage his Type 1 diabetes with the help of his parents and his doctors.
Jul 29, 2022
0
5
Recent work published in JMIR Diabetes reported that previous research has demonstrated the efficacy of a diabetes prevention program (DPP) in lifestyle modifications that can prevent or delay the onset of type 2 diabetes ...
Jul 29, 2022
0
3
A half-century-old diabetes drug appears to help treat bipolar disorder by reversing patients' insulin resistance, according to a small-scale clinical trial.
Jul 27, 2022
0
22
In type 1 diabetes, the body develops immune cells that target pancreatic beta cells, which play a critical role in the production and secretion of insulin. One of the earliest targets of this immune response is a specific ...
Jul 25, 2022
0
130
A new study from ICES and The Hospital for Sick Children (SickKids) finds no overall difference in the relative rate of childhood diabetes in Ontario during the first 18 months of the COVID-19 pandemic.
Jul 25, 2022
0
13
Black adolescents who lived in poverty and were less optimistic about the future showed accelerated aging in their immune cells and were more likely to have elevated insulin resistance at ages 25-29, researchers have found.
Jul 25, 2022
0
58
Sodium–glucose cotransporter 2 (SGLT2) inhibitors, such as empagliflozin, dapagliflozin, canagliflozin and ertugliflozin, have been game changers in the treatment of type 2 diabetes, but their potential for closing the ...
Jul 25, 2022
0
28
